# Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

> **NCT07105384** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 66 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **COMBINATION_PRODUCT:** Radiotracer

## Key facts

- **NCT ID:** NCT07105384
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-04
- **Primary completion:** 2028-06-20
- **Final completion:** 2028-12-20
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07105384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07105384, "Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07105384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*